Intensive follow-up of patients after curative surgery for colorectal cancer is recommended by various scientific societies. However, these recommendations are based mainly on expert opinions, while the results of the few clinical trials are controversial. Moreover, no survival benefit has been demonstrated to date.
Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial
Annals of Oncology | | C. Lepage, J.-M. Phelip, L. Cany, E. Barbier, S. Manfredi, P. Deguiral, M. Laly, M. Baconnier, M. Jary, J.-P. Latrive, E. Terrebonne, A. Lièvre, M. Jafari, M. Ben Abdelghani, J.-F. Ain, G. Breysacher, I. Boillot-Benedetto, A. Pelaquier, P. Prost, J. Ezenfis, Y. Rinaldi, C. Le Foll, O. Berthelet, A. Darut-Jouve, L. Dahan, T. Piche, J.-P. Lagasse, F. Bibeau, P. Laurent-Puig, O. Bouché, PRODIGE 13 investigators/collaborators
Topics: colorectal-cancer, clinical-trials